Literature DB >> 16715186

B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation.

Jingtian Li1, Lexin Wang.   

Abstract

To investigate the levels of B-type natriuretic peptide (BNP) in patients with atrial fibrillation (AF) but without structural heart disease, we measured plasma BNP concentration in 61 consecutive AF patients and in 61 age- and sex-matched healthy subjects. Plasma BNP concentration in the AF group was significantly higher than in the control group (121+/-32 vs 41+/-12 pg/ml, P<0.001). Logistic regression analysis showed that age (r=0.66, P<0.001), left atrial diameter (r=0.59, P<0.01), and a history of AF (r=0.72, P<0.001) were independent predictors of elevated BNP. We concluded that BNP was elevated in patients with paroxysmal lone AF. The clinical significance of BNP elevation in these patients requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715186     DOI: 10.1007/s00380-005-0884-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  18 in total

1.  High plasma brain natriuretic peptide level in thromboembolism patients associated with nonvalvular atrial fibrillation: cause or effect?

Authors:  Shinji Fukui; Naoki Otani; Hiroshi Katoh; Hiroshi Nawashiro; Katsuji Shima
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

2.  Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study.

Authors:  P Jourdain; M Bellorini; F Funck; Y Fulla; N Guillard; J Loiret; B Thebault; N Sadeg; M Desnos
Journal:  Eur J Heart Fail       Date:  2002-06       Impact factor: 15.534

3.  Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.

Authors:  A E Tuinenburg; B J Brundel; I C Van Gelder; R H Henning; M P Van Den Berg; C Driessen; J G Grandjean; W H Van Gilst; H J Crijns
Journal:  J Cardiovasc Electrophysiol       Date:  1999-06

4.  High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation.

Authors:  Hiromi Shimizu; Yo Murakami; Shin-ichi Inoue; Yoko Ohta; Ko Nakamura; Harumi Katoh; Takeshi Sakne; Nobuyuki Takahashi; Shuzo Ohata; Takashi Sugamori; Yutaka Ishibashi; Toshio Shimada
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

5.  Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.

Authors:  Tiemin Wei; Chunlai Zeng; Liping Chen; Qunying Chen; Ruiying Zhao; Ganxin Lu; Chunling Lu; Lexin Wang
Journal:  Eur J Heart Fail       Date:  2005-01       Impact factor: 15.534

6.  Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion.

Authors:  Keizo Tsuchida; Kazuhiko Tanabe
Journal:  J Cardiol       Date:  2004-07       Impact factor: 3.159

7.  Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation.

Authors:  Beata Wozakowska-Kapłon
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

8.  Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm.

Authors:  Craig S Vinch; Jason Rashkin; Giridhar Logsetty; Dennis A Tighe; Jeffrey C Hill; Theo E Meyer; Lawrence S Rosenthal; Gerard P Aurigemma
Journal:  Cardiology       Date:  2004-09-22       Impact factor: 1.869

9.  Alpha 1-adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression.

Authors:  B G Bruneau; L A Piazza; A J de Bold
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

10.  Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.

Authors:  H Yasue; K Obata; K Okumura; M Kurose; H Ogawa; K Matsuyama; M Jougasaki; Y Saito; K Nakao; H Imura
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

View more
  15 in total

1.  NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.

Authors:  Jinqi Fan; Hua Cao; Li Su; Zhiyu Ling; Zengzhang Liu; Xianbin Lan; Yanping Xu; Weijie Chen; Yuehui Yin
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  Georgios K Efthimiadis; Areti Hitoglou-Makedou; Georgios Giannakoulas; Anastasia Mitakidou; Theodoros Karamitsos; Haralambos Karvounis; Sotirios Mochlas; Ioannis Styliadis; Haris Stefanidis; Georgios Parcharidis; Georgios Louridas
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

3.  The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.

Authors:  Yasuki Nakada; Hiroyuki Takahama; Hideaki Kanzaki; Yasuo Sugano; Takuya Hasegawa; Takahiro Ohara; Makoto Amaki; Akira Funada; Akemi Yoshida; Satoshi Yasuda; Hisao Ogawa; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2015-05-12       Impact factor: 2.037

4.  Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds.

Authors:  Tsuneaki Sadanaga; Hideo Mitamura; Shun Kohsaka; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

5.  Long-term results of the maze procedure on left ventricular function for persistent atrial fibrillation associated with mitral valve disease.

Authors:  Yujiro Fukuda; Teruhisa Yoshida; Tomohito Inage; Tomohiro Takeuchi; Takeki Gondo; Eiichi Takii; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-02-18       Impact factor: 2.037

6.  Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?

Authors:  Jayasree Pillarisetti; Namratha Reddy; Mazda Biria; Kay Ryschon; Darbhamulla Nagarajan; Caroline Murray; Donita Atkins; Sudharani Bommana; Madhu Yeruva Reddy; Luigi DiBiase; Rhea Pimentel; Loren Berenbom; Buddhadeb Dawn; Andrea Natale; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2014-05-08       Impact factor: 1.900

7.  Usefulness of rate regulation through continuous ventricular pacing in patients with drug-controlled slower atrial fibrillation and normal or depressed left ventricular systolic function.

Authors:  John Chiladakis; Nikolaos Koutsogiannis; Andreas Kalogeropoulos; Fani Zagli; Panagiotis Arvanitis; Dimitrios Alexopoulos
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

8.  Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.

Authors:  Amir Y Shaikh; Nada Esa; William Martin-Doyle; Menhel Kinno; Iryna Nieto; Kevin C Floyd; Clifford Browning; Cynthia Ennis; J Kevin Donahue; Lawrence S Rosenthal; David D McManus
Journal:  Crit Pathw Cardiol       Date:  2015-12

9.  Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Lisa M Sullivan; Michael J Pencina; James B Meigs; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Philip A Wolf; Jared W Magnani; Patrick T Ellinor; Thomas J Wang; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques.

Authors:  Mindy Vroomen; Laurent Pison
Journal:  J Atr Fibrillation       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.